9 High Growth Stocks With Improving Analyst Sentiment

|
 |  Includes: ARIA, CAST, ISRG, MPEL, RDY, SCOR, SNY, VVUS
by: Kapitall

The following is a list of high growth stocks, as defined by past sales growth and projected EPS growth. All of these stocks have seen improving analyst sentiment over the past three months.

Analyst ratings are presented on a linear scale, where 1 = "Strong Buy" and 5 = "Strong Sell". All of the stocks in our list have seen their ratings move closer to 1, i.e. improving analyst sentiment.

Although analysts still remain cautious on most of these names, the improving sentiment seems to suggest that at least some of the bad news is being priced in by the market. How long before the negative factors are fully priced in? You decide.

Analyst ratings sourced from Reuters, sales and EPS data sourced from Finviz.

Interactive Chart: Press Play to see how annual returns have fluctuated for all the stocks mentioned below.

The list has been sorted by change in analyst rating over the past three months.

1. Dr. Reddy's Laboratories Ltd. (NYSE:RDY): Drug Manufacturers Industry. Market cap of $6.6B. Sales have grown by 29.2% over the last five years, with EPS growth projected at 25.00% over the next 5 years. Analyst rating has changed from 3.5 to 2.0 over the last three months. Short float at 6.1%, which implies a short ratio of 21.25 days. The stock has gained 62.71% over the last year.

2. ChinaCast Education Corporation (OTCPK:CAST): Education & Training Services Industry. Market cap of $391.77M. Sales have grown by 33.88% over the last five years, with EPS growth projected at 30.00% over the next 5 years. Analyst rating has changed from 1.25 to 1.00 over the last three months. Short float at 3.12%, which implies a short ratio of 5.51 days. The stock has gained 3.96% over the last year.

3. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA): Biotechnology Industry. Market cap of $464.38M. Sales have grown by 62.09% over the last five years, with EPS growth projected at 25.00% over the next 5 years. Analyst rating has changed from 1.67 to 1.44 over the last three months. Short float at 8.46%, which implies a short ratio of 8.31 days. The stock has gained 51.24% over the last year.

4. Cimarex Energy Co. (NYSE:XEC): Independent Oil & Gas Industry. Market cap of $6.91B. Sales have grown by 16.27% over the last five years, with EPS growth projected at 45.00% over the next 5 years. Analyst rating has changed from 2.28 to 2.0 over the last three months. Short float at 4.21%, which implies a short ratio of 3.45 days. The stock has gained 78.5% over the last year.

5. VIVUS Inc. (NASDAQ:VVUS): Biotechnology Industry. Market cap of $544.92M. Sales have grown by 20.62% over the last five years, with EPS growth projected at 53.5% over the next 5 years. Analyst rating has changed from 3 to 2.67 over the last three months. Short float at 15.93%, which implies a short ratio of 3.68 days. The stock has lost -13.42% over the last year.

6. Genzyme Corp. (GENZ): Biotechnology Industry. Market cap of $18.14B. Sales have grown by 15.45% over the last five years, with EPS growth projected at 24.32% over the next 5 years. Analyst rating has changed from 2.47 to 2.2 over the last three months. Short float at 8.24%, which implies a short ratio of 5.44 days. The stock has gained 42.11% over the last year.

7. comScore, Inc. (NASDAQ:SCOR): Business Services Industry. Market cap of $662.76M. Sales have grown by 29.63% over the last five years, with EPS growth projected at 39.95% over the next 5 years. Analyst rating has changed from 1.55 to 1.4 over the last three months. Short float at 5.34%, which implies a short ratio of 8.69 days. The stock has gained 32.4% over the last year.

8. Intuitive Surgical, Inc. (NASDAQ:ISRG): Medical Appliances & Equipment Industry. Market cap of $10.54B. Sales have grown by 49.95% over the last five years, with EPS growth projected at 26.19% over the next 5 years. Analyst rating has changed from 2.71 to 2.47 over the last three months. Short float at 7.46%, which implies a short ratio of 4.44 days. The stock has lost -2.3% over the last year.

9. Melco Crown Entertainment Ltd. (NASDAQ:MPEL):
Resorts & Casinos Industry. Market cap of $3.38B. Sales have grown by 178.42% over the last five years, with EPS growth projected at 50.1% over the next 5 years. Analyst rating has changed from 2.69 to 2.33 over the last three months. Short float at 1.3%, which implies a short ratio of 0.73 days. The stock has gained 44.87% over the last year.

Disclosure: No positions